Senior insider sale
Chief Financial Officer at ENTRADA THERAPEUTICS, INC. — senior position signals high conviction
$196.1K
16.64K shares
What this filing means
WENTWORTH KORY JAMES plans to sell 16.64K shares of ENTRADA THERAPEUTICS, INC. valued at approximately $196.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001950047-26-002210
Officer· Chief Financial Officer
Since Oct 2021
16.64K
Shares to sell
$196.1K
Approx. market value
7.99K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/1/2026
7.99KTotal acquired7.99K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2026 | Restricted Stock Units N/A | 7.99K | — |
| Total | 7.99K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.71K
Market value
$67.2K
3/3/2026
—Completed
Units to sell
2.94K
Market value
$34.3K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.99K
Market value
$94.7K
3/4/2026
Total
Units
16.64K
Value
$196.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2026 | 5.71K | $67.2K | — | Completed |
3/2/2026 | 2.94K | $34.3K | — | Completed |
| Planned — Approximate Date | ||||
3/4/2026 | 7.99K | $94.7K | NASDAQ | Planned |
| Total | 16.64K | $196.1K | ||